>>> US Close Dow+0,20% S&P+0,15% Nasdaq+0,50%

Closing Summary: Stocks End Choppy Week on Mixed Note on the week : Dow +0,43% S&P -0,14% Nasdaq -1,26% The stock market finished a choppy week on cautiously optimistic note. The S&P 500 added 0.2% despite spending the bulk of the session in the red. The benchmark index narrowed its week-to-date loss to 0.1%, while the Russell 2000 (+0.9%) trimmed its weekly decline to 1.8%. For its part, the Dow Jones Industrial Average (+0.2%) managed to eke out a slim gain of 0.4% for the week, finishing at a new closing record high at 16,583.34.

Generally speaking, small caps faced the brunt of the selling that took place this week, while some of the money rotated into blue chip listings, allowing indices like the Dow and S&P 500 to stay ahead of their counterparts. Today's session proved to be a bit of a departure from that trend as small caps rebounded, while blue chips struggled to keep pace with their high-beta counterparts.

The S&P 500 spent the first three hours of action stringing together a rebound from its early low. At first, the index was pressured by the four top-weighted sectors, but those groups later separated, leaving the financial sector (-0.1%) among the laggards, while consumer discretionary (+0.6%), health care (+0.6%), and technology (+0.2%) fueled the market-wide bounce.

In particular, the biotech industry was volatile as the iShares Nasdaq Biotechnology ETF (IBB 226.44, +3.09) bounced between its 20- (226.18) and 200-day moving averages (223.16), but ultimately settled closer to its 20-day average with a gain of 1.4%.

Elsewhere, gains in high-beta technology and discretionary components like Facebook (FB 57.24, +0.48), Netflix (NFLX 328.55, +6.89), LinkedIn (LNKD 148.69, +3.62), and Priceline.com (PCLN 1135.91, +27.91) gave a boost to the overall risk sentiment. However, there were still some soft spots among the recent high flyers as Rocket Fuel (FUEL 21.83, -5.98) rocketed lower by 21.5% after its cautious guidance and revenue miss overshadowed its earnings beat.

Unlike momentum names, heavily-weighted tech components were relatively weak. That underperformance was evidenced by the largest member of the tech sector—Apple (AAPL 585.54, -2.45)—which fell 0.4% amid reports the company will acquire Beats Electronics for about $3 billion. In addition, the stock was downgraded to ‘Buy' from ‘Strong Buy' at ISI Group.

On the downside, this year's leading sector—utilities (-1.4%)—spent the session in a steady retreat that trimmed its year-to-date gain to 10.9%. Meanwhile, the second-best sector of the year—energy (-0.2%)—was the second-weakest performer today, narrowing its 2014 advance to 5.2%.

Treasuries surrendered their overnight gains ahead of the open and spent the remainder of the session anchored to their flat lines. The 10-yr yield ended at 2.62%.

Today's participation was below average as less than 640 million shares changed hands at the NYSE.

Economic data was limited to the Wholesale Inventories report for March and the March Jobs Openings and Labor Turnover Survey: • Wholesale inventories increased 1.1% in March after increasing an upwardly revised 0.7% (from 0.5%) in February, while the consensus expected an increase of 1.0%. The BEA assumed that wholesale inventories increased 1.1% in March in the advance estimate of first quarter GDP. The upward revision to February, however, was not built into its model and will result in a positive contribution toward growth in the second estimate. • The Job Openings and Labor Turnover Survey for March indicated job openings decreased to 4.014 million from 4.173 million. On Monday, the Treasury Budget for April will be released at 14:00 ET. Also of note, Ukraine's regions of Donetsk and Lugansk remain scheduled for independence referendums on Sunday. • S&P 500 +1.6% YTD • Dow Jones Industrial Average +0.04% YTD • Nasdaq Composite -2.6% YTD • Russell 2000 -4.6% YTD

>>> MOODYS RAISES PORTUGAL GOVT BOND RATING ONE NOTCH TO Ba2 from Ba3

MOODYS RAISES PORTUGAL GOVT BOND RATING ONE NOTCH TO Ba2 from Ba3; places rating on review for further upgrade - The rating action was triggered by the following key factors: 1) Portugal's fiscal situation has improved more rapidly than initially targeted and the public debt ratio will start declining this year, albeit from a very high level. The budget deficit was reduced a full percentage point of GDP more than envisaged last year, indicating the government's strong commitment to fiscal consolidation. 2) The country will conclude its three-year EU/IMF support programme in the near future, without the need for a precautionary credit line from the European Stability Mechanism (ESM). Portugal has regained access to the public debt markets and in addition the government has built up sizeable cash buffers. 3) Portugal's economic recovery is gaining momentum, with signs of broadening beyond exports, which continue to perform strongly. Moody's believes that economic growth will be sustained over the medium-term because the Portuguese authorities have implemented a wide range of structural reforms. - The review for possible upgrade reflects Moody's view that Portugal's creditworthiness can improve further in the short term, if the rating agency were to conclude that Portugal will likely manage to bring its very high public debt ratio (currently close to 130% of GDP) onto a clear downward path in the coming years. During the review, Moody's will assess the upcoming decisions of Portugal's Constitutional Court on key measures of the 2014 budget. Moody's considers these decisions to be important because the contested measures affect the key government expenditure items of public-sector wages and pensions. In Moody's view, achieving and maintaining low budget deficits over the medium term is difficult without addressing these key spending areas. In addition, the rating agency plans to evaluate the medium-term fiscal plan recently presented by the government and seek greater clarity about the possibility for a broad consensus to emerge on the need to maintain strict fiscal policies beyond the end of the current parliament.

(BFW) Pfizer’s Biggest 25 Holders Own More Than 37% of AstraZeneca

+------------------------------------------------------------------------------+

Pfizer’s Biggest 25 Holders Own More Than 37% of AstraZeneca 2014-05-09 12:36:09.757 GMT

By Allison Connolly and Gaurav Panchal May 9 (Bloomberg) -- Pfizer’s top 25 shareholders own 37.14% of its takeover target AstraZeneca, which has rejected the cash & shares offers twice, based on Bloomberg data. * AstraZeneca is meeting with shareholders this week, while Pfizer sees backlash by Congress, States for its bid

Top Shareholders: Bloomberg data * AstraZeneca: Blackrock 7.75%, AXA 5.45%, Wellington 5.18%, Vanguard 4.79%, Investor AB 4.1%, Invesco 3.7%, Legal & General Group 3.45%, Capital Group 2.86%, State Street 2.8%, Aberdeen 2.39% * On May 6, Investor AB supported rejection of bid * Pfizer: Vanguard 6.91%, Blackrock 6.75%, State Street 4.15%, Capital Group 2.33%, Bank of NY Mellon 1.78%, Northern Trust Corp. 1.55%, Wellington 1.54%, Franklin Resources 1.42%, Massachusetts Financial 1.32%, T. Rowe Price 1.29%

AstraZeneca Ownership Breakdown: * Geography: U.S. 46.08%, U.K. 24.88%, Sweden 5.78%, Ireland 5.46%, France 4.81%, Norway 2.16% * Type: Investment Advisor 85.63%, Govt 4.22%, Banks 3.65%, Pension Fund 2.25%

Short Interest: Markit * AstraZeneca has 0.6% of shares outstanding vs 52-wk high of 0.73% in Dec., 1.9 days to cover vs 52-wk. high of 4.49 in Dec.

Key dates: * May 13: U.K. business secretary Vince Cable faces lawmakers’ questions; AstraZeneca, Pfizer CEOs appear before Business, Innovation and Skills Committee * May 14: AstraZeneca, Pfizer CEOs appear before Science and Technology Committee May 26: Deadline for Pfizer bid, extendable

NOTES: * On May 2: AstraZeneca said Pfizer’s second proposal was inadequate, undervalued company; rejected offer was 1.845 PFE shares plus 1,598p cash for each Astra share * Inital April 28 rejected proposal was 1.758 Pfizer shares, 1,398p cash * Earlier: AstraZeneca investors put money on Pfizer bid bump

For Related News and Information: First Word scrolling panel: FIRST<GO> First Word newswire: NH BFW<GO>

To contact the reporters on this story: Allison Connolly in London at +44-20-3525-7043 or aconnolly4@bloomberg.net; Gaurav Panchal in London at +44-20-7392-0511 or gpanchal2@bloomberg.net To contact the editors responsible for this story: James Ludden at +44-20-7673-2645 or jludden@bloomberg.net Gaurav Panchal

>>> US Gapping down

Gapping down

In reaction to disappointing earnings/guidance: FUEL -31.7% (also multiple downgrades), ACET -13%, JAZZ -10.3% (target lowered to $165 from $195 at Citigroup), SGMS -9%, BRKS -8.9%, SSTK -8.7%, UBNT -8.6%, FF -7.6%, UVE -7.5%, SSYS -7.2%, TUMI -6.9%, ZGNX -6.9%, AIRM -5.9%, (light volume), ELON -5.8%, EAC -5.7% (thinly traded), RL -5.3%, ALSK -4.8%, (light volume), MNST -4.3%, DEPO -3.4%, FPRX -3.2% (light volume), UNXL -2.9%, (light volume), TEF -2.9%, TTI -2.7%, CBS -2.6%, SLXP -2.4%, NES -2.1%, (light volume), MT -2.1%, NVDA -1.6%, BCEI -1.2%, NUAN -0.8%, JMBA -0.7%.

M&A related: OMC -2.7% (Omnicom and Publicis agree to terminate proposed Merger Of Equals), AAPL -0.3% (Apple and Beats nearing $3 bln+ deal, according to FT.com story; downgraded to Buy from Strong Buy at ISI Group).

AAPL / Beat news weighing on select music/electronic names: P -4.5%, SKUL -4.1%, HAR -1.9%.

Other news: LODE -7.4% (plans to make a public offering of its common stock; size not disclosed), HPT -5% (still checking), DDD -3.5% (following SSYS results), CHEF -3.4% (Chefs' Warehouse filed to delay its 10-Q (quarterly report was due on May 7, 2014), KGC -2% (still checking), SDRL -1.9% (still checking), SGY -1.4% ( prices 5 mln share common stock offering at $41 per share),ARMH -1.4% (still checking), ARP -1% (prices public offering of 13.5 mln common units at $19.90 per unit), BSX -0.8% (discloses in 10-Q filing that it was served with a subpoena from the U.S. Department of Health and Human Services on May 5 seeking information relating to the launch of Cognis and Teligen line of devices in 2008), DMND -0.7% (filed for a $500 mln mixed securities shelf offering, 4.45 mln shares of common stock, and for ~4.42 mln shares of common stock offered by selling shareholders).

Analyst comments: MCP -1.6% (downgraded to Underweight from Neutral at JP Morgan), NKA -1.4% ( downgraded to Sell from Neutral at Goldman, TS -1.1% (downgraded to Equal Weight from Overweight at Morgan Stanley), AEE -0.5% (downgraded to Equal Weight from Overweight at Morgan Stanley), WEC -0.4% (downgraded to Sell from Neutral at UBS; tgt lowered to $44 from from $46)

>>> US Gapping up

Gapping up

In reaction to strong earnings/guidance: OLED +13.4%, UEPS +13.1%, HZNP +9.1%,MELI +7.6%, ADEP +7.4%, JOE +6.8%, MDVN +6%, PXLW +5.5%, BEBE +5.4% (light volume), PPO +4.6%, JCOM +4.6% (light volume), GSVC +4.5%, GRUB +4.2%, HLT+3.8%, GPS +3.8%, AL +3.4%, (light volume), CLNE +3.4%, BBOX +3%, (raises its quarterly cash dividend 11% to $0.10 per share), SYMC +2.8%, FXEN +2.8%, (also provides operations update; says it has completed drilling operations on the Tuchola-4K well located on its Edge license in north central Poland, where the co holds 100% working interest ), BLFS +2.5%, (light volume), XOXO +2.2%, (light volume), NWSA +2%, OREX+1.9%, MDRX +1.7%, (upgraded to Buy from Neutral at ISI Group), PBA +1.7%, ALU+1.2%, FULL +1%, (thinly traded), SIRO +1%, GTT +1%, ED +0.7%.

M&A news: IPG +3.2% (reports indicate Interpublic may become takeover target following cancellation of Omnicom (OMC)/ Publicis (PUBGY) merger).

A few solar related names modestly higher: JKS +1.8% ( to Provide 35 MW to Clenera for the Arizona Avalon Solar Project), TSL +0.9%.

Other news: MEIL +9.8% (finalizing arrangements to supply up to 40 railcars of biodiesel per month to U.S. clients), PLUG +7.1% (announces Central Grocers has placed an order for 182 next-generation GenDrive fuel cell units to operate its electric lift truck fleet in Joliet, IL), RSH +2.7% (RadioShack discloses it was not able to obtain consent from lenders for plan to close 1,100 stores; continuing with a plan to close fewer stores and pursuing other cost reduction measures), ARNA +1.6% (Reports that Eisai (ESALY) Plans to Further Increase its Sales Force for BELVIQ (lorcaserin HCl) CIV by 50%), HOLX +1.3% (Barron's profiles positive view on Hologic ), RIG +0.7% (still checking), EOG +0.5% (positive MadMoney mention), WYNN +0.5% (modestly rebounding), ORIG +0.4% (announces first common stock dividend of $0.19 per share), AVP +0.4% (Director bought 37,464 shares at $13.30 - $13.38 on 5/7), AOL +0.3% ( Chairman & CEO discloses purchase of 55.6K shares at $36.08, worth $2.0 mln), NLY +0.2% (announces net lease initiative with Inland Real Estate Group)

Analyst comments: CVA +2.1% ((upgraded at Barclays), LPX +1.2% (upgraded to Buy from Neutral at Longbow), ISIL +1.1% (upgraded to Neutral from Sell at Citigroup), TWTR+0.8% (upgraded to Neutral from Underperform at BofA/Merrill), APU +0.6% (upgraded to Neutral from Underperform at Credit Suisse)

>>> (Makor) Special Situations: CARREFOUR - BUY- target raised to 40+

Special Situations: Carrefour (CA FP)

trade action flash – raising target to Eur 40+ and still a BUY

CA FP: EUR 26.5; target: Eur 40+

May 9, 2014

We have been bullish on Carrefour since early 2012 on the assets values, and particularly on the restructuring potential brought about by the new CEO, Georges Plassat, that came on board in May 2012.  At the time, the market yawned and it took a number of non-core disposals for the stock to start to move up.  A couple weeks ago, the Motier family – descendants of the Galeries Lafayette department stores founders, announced they had acquired in the market a 6.1% stake in the company, thus bringing credibility to the long term turnaround of Carrefour.  Bernard Arnault remains the largest shareholder through two holding companies owning 8.6% of the capital, while Colony owns 5.7%.  Although the shares are up significantly from our initial recommendation, we remain very positive and increase our target from 35 to 40+.  The asset story is still there and is being confirmed at each disposal or deal. The turnaround at the core French operations seems to proceed satisfactorily and could bring an even higher valuation.  Thus the risk could be on the upside rather than the downside.  The stock has corrected from a recent high of near 29 to almost 26 on no real material news.  We consider the current correction in the stock as an excellent opportunity to increase/initiate exposures to this investment. 

As an aside trade, we also recommend to short the Casino French stub – going short Casino and long Pao Acucar (PCAR4 BZ) and Mercyalis (MERY FP) pro-rata of the capital structure.  Casino owns 65% of the share capital of Pao de Acucar and 50% of Mercyalis.  These two listed assets account for Eur 4.5bn, thus valuing the French supermarket business on 5.6bn (Casino’s total market cap is 10.1bn).  We calculate that this French business is being implicitly valued on a EV of 0.74 for operating margins of 3.5%.  This would make it one of the most overvalued food retailing stocks.  We note that both Pao Acucar and Mercyalis are undervalued.  The trade is roughly long 10 PCAR4, long 5 MERY FP / short 10 CO FP.

FULL REPORT ATTACHED

 

Makor Capital

11 Menachem Begin St., 26th FL

Ramat Gan 52681

Israel

 

Tel          +972 3 5453 768

Fax         +972 3 7162 680

 

Research Disclaimer

This publication has been prepared by Makor Capital Limited (“Makor Capital”) and is intended for professional or qualified investors only. Makor Securities LLP (“Makor Securities”)is distributing this material to its clients who are Eligible Counterparties or Professional Clients under FSA Rules. It may also be disseminated to persons who are Investment Professionals within the meaning of the Financial Services and Markets Act 2000 (Financial Promotion) order 2005.  In the United States Makor Capital only distributes this material to major US institutional investors (as that term is defined in Rule 15 a-6 of the Securities and Exchange Act of 1934) and to SEC registered broker-dealers or  banks acting in a broker –dealer capacity” If you do not fall into any of these categories you should disregard it.

 

This research material is a marketing communication.  It is not investment research and has not been prepared in accordance with legal requirements designed to promote the independence of investment research. It is not subject to any prohibition on dealing ahead of the dissemination of investment research.   It has not been produced by Makor Securities. 

 

This material does not take into account the particular investment objectives, financial situation or needs of individual clients or other recipients. Before acting on this material, clients and other recipients should consider whether it is suitable for their particular circumstances and, if necessary, seek professional advice.

This material should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action.

This material is produced by research providers which Makor Securities believes to be reliable, but Makor Securities does not warrant or represent (expressly or impliedly) that it is accurate, complete, not misleading or as to its fitness for the purpose intended and it should not be relied upon as such.

Opinions expressed will be the current opinions of those producing the research as of the date appearing on this material only. We expect those producing the material in  this report to update it on a timely basis but can give no undertaking that they will do so and regulatory compliance or other reasons may prevent  them from doing so (or us from disseminating updated material). 

 

Members and employees of Makor Securities LLP, employees of Makor Capital, Makor Capital Markets and any firm producing this material (including Alternative Investment Management Research SA (“AIM&R”),) may from time to time have long or short positions in securities, warrants, futures, options, derivatives or other financial instruments referred to in this material. For Makor Securities, this information is set out in our Conflicts of Interest Policy which is available on request.  Policies for the production of research from research providers (including AIM&R) are available on request.

Unless otherwise stated, share prices provided within this material are as at the close of business on the day prior to the date of the material.

Neither the whole nor any part of this material may be duplicated in any form or by any means. Neither should any of this material be redistributed or disclosed to anyone without prior consent. This material is issued for general information and discussion purposes only. None of  Makor Securities, Makor Capital, Makor Capital Markets nor AIM&R accepts  liability whatsoever for any direct, indirect or consequential loss or damage of any kind arising out of the use of all or any of this material.

 

The services, securities and investments discussed in this material may not be available to, nor are suitable for all investors. Investors should make their own investment decisions based upon their own financial objectives and financial resources and it should be noted that investment involves risk, including the risk of capital loss. Past performance is no guide to future performance. In relation to securities denominated in foreign currency, movements in exchange rates will have an effect on the value, either favourable or unfavourable.

 

Entities

 

Makor Securities LLP is authorised and regulated by the Financial Services Authority (FSA registration number 556034) of Dover House, 34 Dover Street, London W1S 4NG.

Makor Capital, company number 514456466, is incorporated in Israel and is a 100% held subsidiary of Makor Holdings Pte Ltd incorporated in Singapore.

Makor Capital Markets SA, company number CH-660.2.999.011-0 is incorporated in Switzerland and is also a 100% held subsidiary of Makor Holdings Pte Ltd.

AIM&R is incorporated in Switzerland; company number CH-660.1.533.997-8

 

 

>>> US Early premarket gappers

Early premarket gappers

Gapping up: ADEP +11.8%, UEPS +9.9%, MEIL +9.8%, OLED +9.8%, GPS +8.6%, MELI +7.6%, JOE +6.8%, MDVN +6%, PXLW +5.5%, BEBE +5.4%, PPO +4.6%, JCOM +4.6%, GRUB +4.2%, GSVC +3.9%, AL +3.4%, CLNE +3.4%, BBOX +3%, SYMC +2.8%, FXEN +2.8%, RSH +2.7%, BLFS +2.5%, XOXO +2.2%, NWSA +2%, JKS +1.8%, PBA +1.7%, ALU +1.2%, FULL +1%,TWTR +0.8%, RIG +0.7%

Gapping down: FUEL -27.8%, SGMS -14%, FF -13.3%, ACET -13%, JAZZ -9.5%, BRKS -8.9%, SSTK -8.7%, UBNT -8.6%, UVE -7.5%, TUMI -6.9%, ZGNX -6.9%, AIRM -5.9%, ELON -5.8%, EAC -5.7%, P -4.5%, MNST -4.3%, DEPO -4.2%, SKUL -4.1%, LODE -3.7%, CHEF -3.4%, BCEI -3.3%, FPRX -3.2%, UNXL -2.9%, OMC -2.7%, CBS -2.6%, DDD -2.5%, SLXP -2.4%, NES -2.1%,MT -2.1%, SDRL -1.9%, NVDA -1.6%, SGY -1.4%, ARP -1%, BSX -0.8%, DMND -0.7%

>>> What to look at today - 09/05/2014

US Market closed Mixed again, The stock market ended the Thursday session on a defensive note despite
showing early strength. The S&P 500 lost 0.1%, while the tech-heavy Nasdaq (-0.4%) fell nearly 60 points from its session high. Also of note, the Russell 2000 (-1.0%) settled below its 200-day moving average after failing to retake that level during the session...volumes were below average @ 700mil shares...FX was an important catalyst for the move on equities today...VIX @ 13,43 +0,22%...After Hours : OLED +10.8%, MELI +7.6%, ADEP +7.4%, MDVN +5.8%, SMSI -29.5%, FUEL -27%, JAZZ -9.2% following earnings/guidance

Eur$ 1,3843 S&P Fut European Fut

Macro
- *CHINA APRIL CONSUMER PRICES RISE 1.8%; EST. 2.1% GAIN

Keep an eye on :
- PUB FP : Omnicom and Publicis Call Off Merger
- ACS SM : ACS 1Q Net Profit EU202 Mln; Analyst Est. EU171.6 Mln
- ALO FP : France Would Ask GE to Sell Alstom Wind to Areva: Les Echos
- ALO FP : GE Says Not Talking With Toshiba About Alstom Unit: Reuters Link
- AZN LN : EU Would Veto U.K. Govt Intervention in AstraZeneca Bid: Reuters
- AZNLN : AstraZeneca Investors Put Money on Pfizer Bid Bump: Real M&A {NSN N5A3NO6JTSEW <go>}
- CMA FP : Ciments Francais 1Q Net Loss EU13.5m vs Profit EU0.5m Y/y
- F IM : Marchionne Says Fiat Chrysler HQ Will Be in London
- GAM SM : Gamesa 1Q Net EU17 Mln; Analyst Est. EU13.2 Mln
- MSK IM : Moleskine Reiterates 2014 Rev, Ebitda Forecasts
- ORA FP : Canal Plus in Talks With Orange on Buying Dailymotion Stake: FT
- PUB FP : Ad Agency Giants Said to Call Off $35 Billion Merger {http://nyti.ms/1ovdeQr} - NYT
- SZG GY : Salzgitter Posts 1Q Pretax Loss of EU8.7m vs EU16.1m Loss y/y
- VIV FP : Apple in Talks to Buy Beats Electronics
- ZIGGO NA : Liberty Global Remains Confident Ziggo Deal to Close in 2H 2014